Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vinorelbine + cisplatin with concurrent radiotherapy for stage III non-small cell lung cancer
ACTRN12609000003279Phase 2Recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine and cisplatin in non-small cell lung cancer (NSCLC), sponsored by Royal Adelaide Hospital. Primary endpoint: Progression-free survival. Started Aug 2008; status: recruiting.
02
Drugs
vinorelbinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ACTRN12609000003279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000003279.